Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
6 Hints to Upgrade Your Appeal, In addition to Your Outlook - 2What causes RFK Jr.’s strained and shaky voice? A neurologist explains this little-known disorder
- 3Creative Style: 10 Architects Reclassifying the Business
- 4Portable Installment Answers for Independent ventures
- 5The Way to Monetary Freedom: A Viable Aide
- Alice Wong, founder of the Disability Visibility Project, dies at 51
- The most effective method to Boost Benefits in Gold Speculation: Master Techniques and Tips
- Which Instax Camera Would it be a good idea for you to Purchase?
- 10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- Worldwide Objections Ideal For A Golf Outing
- 7 Methods for further developing Rest Quality
- 10 High priority Contraptions for Tech Aficionados
- Bring tissues and skip the mascara: The movie that's making theater-goers sob uncontrollaby
- The capacity to understand people on a profound level: Exploring Life's Intricacies
